Lack of Genetic and Epigenetic Changes in CDKN2A in Melanocytic Nevi

This publication has 14 references indexed in Scilit:

• CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma
  JNCI Journal of the National Cancer Institute, 1999
• Genetic Alterations ofp16INK4aandp53Genes in Sporadic Dysplastic Nevus
  Biochemical and Biophysical Research Communications, 1997
• Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
  JNCI Journal of the National Cancer Institute, 1997
• Infrequent Mutation of p16INK4 in Sporadic Melanoma
  Journal of Investigative Dermatology, 1996
• The current situation with regard to human melanoma and genetic inferences
  Current Opinion in Oncology, 1996
• CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families
  Melanoma Research, 1995
• A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
  Science, 1994
• Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
  Nature, 1994
• High sensitivity mapping of methylated cytosines
  Nucleic Acids Research, 1994
• High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi
  Annals of Internal Medicine, 1985